Medication underuse in real-life practice: the impact of galcanezumab towards achieving very low frequency episodic migraine in a southeast Asian middle-income nation

Abstract Background Migraine progression, particularly from episodic to chronic migraine (CM), increases disease burden and healthcare costs. Understanding the new concept of “Medication Underuse Headache” should encourage the health care provider to consider early intervention with calcitonin gene-...

全面介紹

書目詳細資料

發表在:	The Journal of Headache and Pain
Main Authors:	Wanakorn Rattanawong, Prakit Anukoolwittaya, Akarin Hiransuthikul, Thanakit Pongpitakmetha, Auranee Trisataya, Sekh Thanprasertsuk, Alan Rapoport
格式:	Article
語言:	英语
出版:	BMC 2025-01-01
主題:	Medication underuse headache Galcanezumab Very low frequency episodic migraine Preventive medication
在線閱讀:	https://doi.org/10.1186/s10194-025-01952-1